- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
This drug maker has risen more than 17% this year. But investors may want to say cautious, unless they are super-aggressive.
The $5.2 billion takeout of Ariad Pharma was the biggest news from the closely followed healthcare conference.
Every January at 'JPM,' investors take the pulse of the biotech industry for the coming year.